Consultation on inactivation of role groupers in Substance and Medicinal Product hierarchies
Summary
A briefing note is to solicit feedback on the proposal to inactivate role groupers in the Substance hierarchy and the Medicinal Product hierarchy. Please see the PDF for further details.
Relevant documents
Actions:
Date | Requested action | Requester(s) | Response required by: |
|---|---|---|---|
Nov 7, 2023 | Please provide feedback and comments to info@snomed.org by December 15th, 2023 31st January 2024 (marked in the heading for the attention of Nicki Ingram and Farzaneh Ashrafi). Feedback period extended. | Nicola Ingram Farzaneh Ashrafi | Camilla Wiberg Danielsen Louise Bie Anna Harasim (Unlicensed) Elze de Groot (Unlicensed) Theresa Barry Former user (Deleted) Libby Antoun (Unlicensed) Katrien Scheerlinck (Unlicensed) Keng-Ling Wallin (Unlicensed) |
Comments
Thank you Former user (Deleted) and it was great to meet you and your colleague Robert Wynne in Atlanta.
Thank you for your presentation comparing therapeutic classes between MED-RT and SNOMED CT. Does MED-RT have international usage outside of the US? Is there a mapping to SNOMED CT? https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/MED-RT/index.html
We are collating all feedback from our consultation and will be creating a Briefing Note in due course for circulation to stakeholders.
Farzaneh Ashrafi Jim Case Monica Harry Jane Millar
Therapeutic roles in SNOMED CT have been studied and compared to the MED-RT classification. See this presentation at the SNOMED Expo in 2022:
While this investigation does not directly answer the questions posed in the briefing, it sheds some light on the potential usefulness of the therapeutic roles and offers some replacement solution for them.